Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality

E-ISSN： 1873-4286|19|21|3841-3857

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.21, 2013-06, pp. : 3841-3857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M. Ormrod D. Jarvis B.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1494-1503

Bentham Science Publishers

Access to resources Recommend Favorite

High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?

Current Medicinal Chemistry, Vol. 21, Iss. 25, 2014-08 ,pp. : 2917-2926

Bentham Science Publishers

Access to resources Recommend Favorite

Significance of High Density Lipoprotein-Cholesterol in Cardiovascular Risk Prevention: Recommendations of the HDL Forum1 1 Affiliation details for individual members of the HDL Forum are available in the Acknowledgments section.

By Juan F. Ascaso

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 299-314

Adis International

Access to resources Recommend Favorite

High Density Lipoprotein Cholesterol and Statin Trials

Current Medicinal Chemistry, Vol. 15, Iss. 22, 2008-09 ,pp. : 2265-2270

Bentham Science Publishers

Access to resources Recommend Favorite